{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T23:06:15Z","timestamp":1778540775127,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81370373"],"award-info":[{"award-number":["81370373"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81620108001"],"award-info":[{"award-number":["81620108001"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Priority Academic Development Program of Jiangsu Higher Education Institutions"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.bbrc.2016.11.003","type":"journal-article","created":{"date-parts":[[2016,11,3]],"date-time":"2016-11-03T08:32:40Z","timestamp":1478161960000},"page":"147-153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Glaucocalyxin A improves survival in bleomycin-induced pulmonary fibrosis in mice"],"prefix":"10.1016","volume":"482","author":[{"given":"Fei","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiren","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"You","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2016.11.003_bib1","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/S0140-6736(11)60052-4","article-title":"Idiopathic pulmonary fibrosis","volume":"378","author":"King","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.bbrc.2016.11.003_bib2","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1398-9995.2005.00719.x","article-title":"Idiopathic pulmonary fibrosis","volume":"60","author":"Harari","year":"2005","journal-title":"Allergy"},{"key":"10.1016\/j.bbrc.2016.11.003_bib3","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1164\/rccm.200209-1112OC","article-title":"Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia","volume":"168","author":"Flaherty","year":"2003","journal-title":"Am. J. Respir. Crit. care Med."},{"key":"10.1016\/j.bbrc.2016.11.003_bib4","doi-asserted-by":"crossref","first-page":"136","DOI":"10.7326\/0003-4819-134-2-200101160-00015","article-title":"Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy","volume":"134","author":"Selman","year":"2001","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.bbrc.2016.11.003_bib5","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1183\/09059180.00010904","article-title":"Epithelial fibroblast triggering and interactions in pulmonary fibrosis","volume":"17","author":"Noble","year":"2008","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.bbrc.2016.11.003_bib6","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1183\/09059180.00010911","article-title":"Elucidating the causes and examining the latest clinical findings in pulmonary fibrosis: recent progress and future objectives","volume":"17","author":"du Bois","year":"2008","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.bbrc.2016.11.003_bib7","first-page":"114","article-title":"Myofibroblasts and their role in lung collagen gene expression during pulmonary fibrosis. A combined immunohistochemical and in situ hybridization study","volume":"145","author":"Zhang","year":"1994","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbrc.2016.11.003_bib8","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1080\/14786419.2014.934235","article-title":"Glaucocalyxin A: a review","volume":"28","author":"Xiang","year":"2014","journal-title":"Nat. Prod. Res."},{"key":"10.1016\/j.bbrc.2016.11.003_bib9","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.3892\/ol.2015.4002","article-title":"Glaucocalyxin A inhibits the growth of liver cancer Focus and SMMC-7721 cells","volume":"11","author":"Tang","year":"2016","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bbrc.2016.11.003_bib10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.tiv.2010.09.006","article-title":"Glaucocalyxin A induces apoptosis in human leukemia HL-60 cells through mitochondria-mediated death pathway","volume":"25","author":"Gao","year":"2011","journal-title":"Toxicol. In\u00a0Vitro"},{"key":"10.1016\/j.bbrc.2016.11.003_bib11","doi-asserted-by":"crossref","first-page":"5805","DOI":"10.7314\/APJCP.2013.14.10.5805","article-title":"Glaucocalyxin A activates FasL and induces apoptosis through activation of the JNK pathway in human breast cancer cells","volume":"14","author":"Li","year":"2013","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.bbrc.2016.11.003_bib12","doi-asserted-by":"crossref","first-page":"e55792","DOI":"10.1371\/journal.pone.0055792","article-title":"Regulation of microglia activity by glaucocalyxin-A: attenuation of lipopolysaccharide-stimulated neuroinflammation through NF-\u03baB and p38 MAPK signaling pathways","volume":"8","author":"Kim","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2016.11.003_bib13","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1021\/np0705965","article-title":"ent-Kaurane diterpenoids from Isodon japonicus","volume":"71","author":"Hong","year":"2008","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.bbrc.2016.11.003_bib14","doi-asserted-by":"crossref","first-page":"e85120","DOI":"10.1371\/journal.pone.0085120","article-title":"Glaucocalyxin A inhibits platelet activation and thrombus formation preferentially via GPVI signaling pathway","volume":"8","author":"Li","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.bbrc.2016.11.003_bib15","first-page":"1216","article-title":"Protective effect of glaucocalyxin A inhibits H2O2-induced H9c2 cardiomyocytes injury","volume":"33","author":"Liu","year":"2014","journal-title":"Lat. Am. J. Pharm."},{"key":"10.1016\/j.bbrc.2016.11.003_bib16","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0022-5223(19)35265-1","article-title":"Randomized clinical trial of preoperative and postoperative adjuvant chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the esophagus","volume":"96","author":"Roth","year":"1988","journal-title":"J.\u00a0Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.bbrc.2016.11.003_bib17","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1084\/jem.170.3.655","article-title":"Tumor necrosis factor\/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis","volume":"170","author":"Piguet","year":"1989","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.bbrc.2016.11.003_bib18","first-page":"185","article-title":"The pathogenesis of bleomycin-induced pulmonary fibrosis in mice","volume":"77","author":"Adamson","year":"1974","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbrc.2016.11.003_bib19","doi-asserted-by":"crossref","first-page":"L891","DOI":"10.1152\/ajplung.00333.2007","article-title":"PPAR-\u03b3 agonists inhibit profibrotic phenotypes in human lung fibroblasts and bleomycin-induced pulmonary fibrosis","volume":"294","author":"Milam","year":"2008","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.bbrc.2016.11.003_bib20","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1476-5381.2008.00041.x","article-title":"Roflumilast, a phosphodiesterase 4 inhibitor, alleviates bleomycin-induced lung injury","volume":"156","author":"Cortijo","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2016.11.003_bib21","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative CT method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bbrc.2016.11.003_bib22","doi-asserted-by":"crossref","first-page":"326ra320","DOI":"10.1126\/scitranslmed.aad7785","article-title":"Deglycosylated bleomycin has the antitumor activity of bleomycin without pulmonary toxicity","volume":"8","author":"Burgy","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbrc.2016.11.003_bib23","doi-asserted-by":"crossref","first-page":"L895","DOI":"10.1152\/ajplung.2000.279.5.L895","article-title":"SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lung","volume":"279","author":"Underwood","year":"2000","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.bbrc.2016.11.003_bib24","first-page":"3786","article-title":"IL-1R1\/MyD88 signaling and the inflammasome are essential in pulmonary inflammation and fibrosis in mice","volume":"117","author":"Gasse","year":"2007","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.bbrc.2016.11.003_bib25","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/j.ajpath.2016.03.020","article-title":"CD4(+)CD25(hi)Foxp3(+) cells exacerbate bleomycin-induced pulmonary fibrosis","volume":"186","author":"Birjandi","year":"2016","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbrc.2016.11.003_bib26","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/nm.2807","article-title":"Mechanisms of fibrosis: therapeutic translation for fibrotic disease","volume":"18","author":"Wynn","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2016.11.003_bib27","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.pupt.2014.04.008","article-title":"Thrombomodulin for acute exacerbations of idiopathic pulmonary fibrosis: a proof of concept study","volume":"29","author":"Tsushima","year":"2014","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.bbrc.2016.11.003_bib28","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2169\/internalmedicine.51.6965","article-title":"Polymyxin B-immobilized fiber column (PMX) treatment for idiopathic pulmonary fibrosis with acute exacerbation: a multicenter retrospective analysis","volume":"51","author":"Abe","year":"2012","journal-title":"Intern Med."},{"key":"10.1016\/j.bbrc.2016.11.003_bib29","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1183\/09031936.06.00032605","article-title":"Long-term clinical effects of interferon gamma-1b and colchicine in idiopathic pulmonary fibrosis","volume":"28","author":"Antoniou","year":"2006","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.bbrc.2016.11.003_bib30","doi-asserted-by":"crossref","first-page":"L152","DOI":"10.1152\/ajplung.00313.2007","article-title":"Murine models of pulmonary fibrosis","volume":"294","author":"Moore","year":"2008","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.bbrc.2016.11.003_bib31","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.cyto.2014.09.005","article-title":"Contributions of cell subsets to cytokine production during normal and impaired wound healing","volume":"71","author":"Mirza","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.bbrc.2016.11.003_bib32","doi-asserted-by":"crossref","first-page":"L526","DOI":"10.1152\/ajplung.00131.2002","article-title":"Intratracheal gene transfer of decorin reduces subpleural fibroproliferation induced by bleomycin","volume":"284","author":"Shimizukawa","year":"2003","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.bbrc.2016.11.003_bib33","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1258\/ebm.2011.011280","article-title":"Effects of RNA interference-induced Smad3 gene silencing on pulmonary fibrosis caused by paraquat in mice","volume":"237","author":"Dong","year":"2012","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.bbrc.2016.11.003_bib34","doi-asserted-by":"crossref","first-page":"L790","DOI":"10.1152\/ajplung.00300.2004","article-title":"Bleomycin initiates apoptosis of lung epithelial cells by ROS but not by Fas\/FasL pathway","volume":"290","author":"Wallach-Dayan","year":"2006","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.bbrc.2016.11.003_bib35","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1165\/rcmb.2008-0182OC","article-title":"Role of proinflammatory cytokines IL-18 and IL-1beta in bleomycin-induced lung injury in humans and mice","volume":"41","author":"Hoshino","year":"2009","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.bbrc.2016.11.003_bib36","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1080\/08958370252870998","article-title":"Time course of pulmonary response of rats to inhalation of crystalline silica: NF-kappa B activation, inflammation, cytokine production, and damage","volume":"14","author":"Porter","year":"2002","journal-title":"Inhal. Toxicol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X16318514?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X16318514?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,27]],"date-time":"2020-09-27T03:16:45Z","timestamp":1601176605000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X16318514"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S0006291X16318514"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2016.11.003","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glaucocalyxin A improves survival in bleomycin-induced pulmonary fibrosis in mice","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2016.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}